The effect of fibrillar matrix architecture on tumor cell invasion of physically challenging environments

Biomaterials

Volumn 35, Issue 25, 2014, Pages 6954-6963

  Guzman, Asja ^a   Ziperstein, Michelle J ^a   Kaufman, Laura J ^a  

^a Department of Chemistry Columbia University ^*  (United States)

Author keywords

3D; Breast cancer; Cell invasion; Collagen; Extracellular matrix

Indexed keywords

COLLAGEN; CYTOLOGY; DISEASES; EMBEDDED SYSTEMS; MACHINERY; VISCOELASTICITY;

3D; BIOPHYSICAL CHARACTERISTICS; BREAST CANCER; BREAST CANCER CELLS; CELL INVASION; EXTRACELLULAR MATRICES; NON-FIBRILLAR MATRIXES; VISCOELASTIC PROPERTIES;

CELLS;

COLLAGEN TYPE 1; FIBRILLAR COLLAGEN;

ARTICLE; BASEMENT MEMBRANE; BASEMENT MEMBRANE EXTRACT; BREAST ADENOCARCINOMA; CANCER CELL; CELL AGGREGATION; CELL CULTURE; CELL INVASION; CELL POLARITY; ENVIRONMENT; EXTRACELLULAR MATRIX; FLOW KINETICS; HUMAN; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MECHANOTRANSDUCTION; MULTICELLULAR SPHEROID; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; RAT; THREE DIMENSIONAL IMAGING; TUMOR SPHEROID; VISCOELASTICITY; CHEMISTRY; DRUG EFFECTS; FEMALE; POROSITY; TUMOR CELL LINE;

BASEMENT MEMBRANE; CELL LINE, TUMOR; CELL POLARITY; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FEMALE; FIBRILLAR COLLAGENS; HUMANS; MECHANOTRANSDUCTION, CELLULAR; POROSITY;

EID: 84902083072     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.086     Document Type: Article

References (49)

1. Kothapalli D., Liu S.L., Bae Y.H., Monslow J., Xu T., Hawthorne E.A., et al. Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening. Cell Rep 2012, 2:1259-1271.
2. Georges P.C., Hui J.J., Gombos Z., McCormick M.E., Wang A.Y., Uemura M., et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G1147-G1154.
3. Cox T.R., Erler J.T. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 2011, 4:165-178.
4. Perepelyuk M., Terajima M., Wang A.Y., Georges P.C., Janmey P.A., Yamauchi M., et al. Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol 2013, 304:G605-G614.
5. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
6. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
7. Kumar S., Weaver V.M. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 2009, 28:113-127.
8. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. JCell Biol 2012, 196:395-406.
9. Cil T., Fishell E., Hanna W., Sun P., Rawlinson E., Narod S.A., et al. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer 2009, 115:5780-5787.
10. Boyd N.F., Martin L.J., Yaffe M.J., Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011, 13:223.
11. Alowami S., Troup S., Al-Haddad S., Kirkpatrick I., Watson P.H. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003, 5:R129-R135.
12. Guo Y.P., Martin L.J., Hanna W., Banerjee D., Miller N., Fishell E., et al. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 2001, 10:243-248.
13. Deak S.B., Glaug M.R., Pierce R.A., Bancila E., Amenta P., Mackenzie J.W., et al. Desmoplasia in benign and malignant breast disease is characterized by alterations in level of mRNAs coding for types I and III procollagen. Matrix 1991, 11:252-258.
14. Kauppila S., Stenback F., Risteli J., Jukkola A., Risteli L. Aberrant type I and type III collagen gene expression in human breast cancer invivo. JPathol 1998, 186:262-268.
15. Bergamaschi A., Tagliabue E., Sorlie T., Naume B., Triulzi T., Orlandi R., et al. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. JPathol 2008, 214:357-367.
16. Krouskop T.A., Wheeler T.M., Kallel F., Garra B.S., Hall T. Elastic moduli of breast and prostate tissues under compression. Ultrason Imaging 1998, 20:260-274.
17. Chang J.M., Park I.A., Lee S.H., Kim W.H., Bae M.S., Koo H.R., et al. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer. Eur Radiol 2013, 23:2450-2458.
18. Lo C.M., Wang H.B., Dembo M., Wang Y.L. Cell movement is guided by the rigidity of the substrate. Biophys J 2000, 79:144-152.
19. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
20. Zaman M.H., Trapani L.M., Sieminski A.L., Mackellar D., Gong H., Kamm R.D., et al. Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci U S A 2006, 103:10889-10894.
21. Ulrich T.A., Lee T.G., Shon H.K., Moon D.W., Kumar S. Microscale mechanisms of agarose-induced disruption of collagen remodeling. Biomaterials 2011, 32:5633-5642.
22. Pathak A., Kumar S. Independent regulation of tumor cell migration by matrix stiffness and confinement. Proc Natl Acad Sci U S A 2012, 109:10334-10339.
23. Ehrbar M., Sala A., Lienemann P., Ranga A., Mosiewicz K., Bittermann A., et al. Elucidating the role of matrix stiffness in 3D cell migration and remodeling. Biophys J 2011, 100:284-293.
24. Beck J.N., Singh A., Rothenberg A.R., Elisseeff J.H., Ewald A.J. The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination. Biomaterials 2013, 34:9486-9495.
25. Provenzano P.P., Eliceiri K.W., Campbell J.M., Inman D.R., White J.G., Keely P.J. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006, 4:38.
26. Conklin M.W., Eickhoff J.C., Riching K.M., Pehlke C.A., Eliceiri K.W., Provenzano P.P., et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 2011, 178:1221-1232.
27. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. JCell Biol 2003, 160:267-277.
28. Kaufman L.J., Brangwynne C.P., Kasza K.E., Filippidi E., Gordon V.D., Deisboeck T.S., et al. Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns. Biophys J 2005, 89:635-650.
29. Raub C.B., Suresh V., Krasieva T., Lyubovitsky J., Mih J.D., Putnam A.J., et al. Noninvasive assessment of collagen gel microstructure and mechanics using multiphoton microscopy. Biophys J 2007, 92:2212-2222.
30. Yang Y.L., Leone L.M., Kaufman L.J. Elastic moduli of collagen gels can be predicted from two-dimensional confocal microscopy. Biophys J 2009, 97:2051-2060.
31. Fu Y., Chin L.K., Bourouina T., Liu A.Q., VanDongen A.M. Nuclear deformation during breast cancer cell transmigration. Lab Chip 2012, 12:3774-3778.
32. Straight A.F., Cheung A., Limouze J., Chen I., Westwood N.J., Sellers J.R., et al. Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science 2003, 299:1743-1747.
33. Kovacs M., Toth J., Hetenyi C., Malnasi-Csizmadia A., Sellers J.R. Mechanism of blebbistatin inhibition of myosin II. JBiol Chem 2004, 279:35557-35563.
34. Yurchenco P.D., Ruben G.C. Basement-membrane structure in situ - evidence for lateral associations in the type-IV collagen network. JCell Biol 1987, 105:2559-2568.
35. Abrams G.A., Goodman S.L., Nealey P.F., Franco M., Murphy C.J. Nanoscale topography of the basement membrane underlying the corneal epithelium of the rhesus macaque. Cell Tissue Res 2000, 299:39-46.
36. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003, 3:422-433.
37. Yang Y.L., Motte S., Kaufman L.J. Pore size variable type I collagen gels and their interaction with glioma cells. Biomaterials 2010, 31:5678-5688.
38. Wolf K., Te Lindert M., Krause M., Alexander S., Te Riet J., Willis A.L., et al. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. JCell Biol 2013, 201:1069-1084.
39. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996, 2:461-462.
40. Nakopoulou L., Giannopoulou I., Gakiopoulou H., Liapis H., Tzonou A., Davaris P.S. Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999, 30:436-442.
41. McGowan P.M., Duffy M.J. Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Ann Oncol 2008, 19:1566-1572.
42. Butler G.S., Overall C.M. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry 2009, 48:10830-10845.
43. Nguyen-Ngoc K.V., Cheung K.J., Brenot A., Shamir E.R., Gray R.S., Hines W.C., et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A 2012, 109:E2595-E2604.
44. Mierke C.T., Frey B., Fellner M., Herrmann M., Fabry B. Integrin alpha5beta1 facilitates cancer cell invasion through enhanced contractile forces. JCell Sci 2011, 124:369-383.
45. Plow E.F., Haas T.A., Zhang L., Loftus J., Smith J.W. Ligand binding to integrins. JBiol Chem 2000, 275:21785-21788.
46. Nishiuchi R., Takagi J., Hayashi M., Ido H., Yagi Y., Sanzen N., et al. Ligand-binding specificities of laminin-binding integrins: a comprehensive survey of laminin-integrin interactions using recombinant alpha3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol 2006, 25:189-197.
47. Charras G., Paluch E. Blebs lead the way: how to migrate without lamellipodia. Nat Rev Mol Cell Biol 2008, 9:730-736.
48. Meyer A.S., Hughes-Alford S.K., Kay J.E., Castillo A., Wells A., Gertler F.B., et al. 2D protrusion but not motility predicts growth factor-induced cancer cell migration in 3D collagen. JCell Biol 2012, 197:721-729.
49. Klemke R.L. Trespassing cancer cells: 'fingerprinting' invasive protrusions reveals metastatic culprits. Curr Opin Cell Biol 2012, 24:662-669.